Although scarlet fever antitoxin has been in use for seven or eight years, there is still considerable difference of opinion as to its place in the treatment of scarlet fever. This is largely owing to the fact that there have been few detailed reports on a sufficiently large series of treated and untreated patients comparable in age and severity of infection.
During 1931-32 there was an extensive outbreak of scarlet fever in Glasgow, and an opportunity wTas thus afforded of carrying out observations on the therapeutic value of scarlet fever antitoxin. Records were kept of 1,616 cases of scarlet fever admitted between October, 1931, and October, 1932. These records were wholly clinical and, save in a very fewT instances, wTere made by the writer. The scarlet fever was not on the average a severe infection, at all events as regards initial intoxication, and even in the more severe cases the initial toxaemia was seldom of a degree which 
